Who Optimizes SG&A Costs Better? Opthea Limited or Perrigo Company plc

Optimizing SG&A: A Tale of Two Companies

In the competitive world of business, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Opthea Limited and Perrigo Company plc, two prominent players in their respective industries, offer a fascinating study in cost optimization over the past decade.

Opthea Limited: A Steady Climb

Opthea Limited, a biotechnology firm, has seen its SG&A expenses grow from approximately $2.7 million in 2014 to a peak of $41.9 million in 2023. This represents a staggering increase of over 1,450%. However, the 2024 projection shows a significant reduction, indicating a strategic shift towards cost efficiency.

Perrigo Company plc: Consistent Management

Perrigo Company plc, a global healthcare supplier, has maintained a more stable SG&A trajectory. Starting at $675 million in 2014, their expenses have gradually increased to $1.27 billion in 2023, reflecting a more controlled growth of around 88%.

Conclusion

While Opthea's expenses have fluctuated, Perrigo's consistent management highlights their effective cost control strategies. Missing data for 2024 suggests ongoing adjustments, making future trends worth watching.